Wednesday, August 15, 2018
 
 
Company News: Page (1) of 1 - 07/17/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Healthcare 3D Printing Market will register 21.2% CAGR to cross $2.2 billion by 2024: Global Market Insights, Inc.

(July 17, 2018)

Healthcare 3D Printing Market Size By Product, By Technology, By Application and Regional Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, Russia, China, India, Japan, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia), Application Potential, Competitive Market Share & Forecast, 2018 – 2024

Sellbyville, Delaware, July 17, 2018 (GLOBE NEWSWIRE) --

The Healthcare 3D Printing Market is poised to beat USD 2.2 billion by 2024; according to a new research report by Global Market Insights, Inc. Increasing number of patients suffering from chronic diseases as well as more number of road accidents will substantially augment demand for healthcare 3D printing market. Trending developments associated with surgical prosthesis, pharmaceuticals and medical devices should upsurge revenue size. Rising technological advancements in healthcare 3D printing will favor market growth over the coming years. Moreover, many hospitals have adopted technologically advanced devices that will enhance the business growth.

Launch of enhanced 3D printed devices through innovative research should foster market growth. Numerous research centers such as Organovo involve scientists in making artificial organs to study drug effects on functioning of organs. Additionally, prominent industry players are emphasizing efforts on R&D to introduce enhanced 3D printed products enabling scanning through smartphone devices. Aforementioned aspects should stimulate business growth over the forecast period. However, high cost associated with 3D printing software will impede global market growth during the forecast period.



Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/1997

Syringe based segment held largest revenue of USD 237.5 million in 2017. Segmental growth is attributable to advantages provided by syringe-based printers and escalating demand for syringe-based printers. Advantages offered by syringe-based printers include adaptability, simplicity and ease of controlling the flow rate of material.

Laser based segment accounted for 18.6% market share in 2017, owing to growing usage of laser-based 3D printers for the process of DNA synthesizing. Moreover, laser printer speeds up the procedure of DNA printing thereby, making it affordable and facilitating effective formulation of medicines.

Browse key industry insights spread across 150 pages with 118 market data tables & 9 figures & charts from the report, “Healthcare 3D Printing Market” in detail along with the table of contents:

https://www.gminsights.com/industry-analysis/healthcare-3D-printing-market

Selective laser sintering (SLS) technology held USD 164.9 million and is estimated to grow significantly during forecast timeline. The segmental growth is attributable to wide-ranging applications in manufacturing of medical products, aerospace, healthcare, military hardware and consumer goods. In addition to SLS is extremely appropriate for bulky customization as well as custom-made manufacturing in small batches that should foster demand for SLS.

 Dental application is projected to grow at 20.5% over the forecast period due to accessible customization at affordable price, and high acceptability by patients. It also allows surgeons to customize and cast mold according to patients’ preference through digital scan software such as, AutoCAD and is expected to encourage customer buying behaviour.

U.S. market accounted for 91.1% revenue share of North America in 2017, owing to rising demand coupled with availability of advanced products that includes, kidney models, 3D printed bone, dental guides, 3D printable pill, ear implants, and automated suturing devices.

 UK market held USD 31.5 million in 2017 and will witness robust growth over the forecast timeline due to rising adoption of innovative technologies. UK has massive number of local 3D manufacturing hubs as well as they provide training program with an objective to produce wide variation of prosthetic devices. This will act as a growth rendering factor over the coming years.

 Key business competitors functioning in global market are Aprecia Pharmaceuticals, Aspect Biosystems, Bio 3D Technologies, BioBots, Cyfuse Biomedical, Digilab, 3Dynamics Systems, Envision TEC, Luxexcel, Materialise NV, Nano3D Biosciences, Oceanz, Organovo Holdings, regenHU, Renishaw, Solidscape, Stratasys, TeVido BioDevices, 3D Bioprinting Solutions, 3D Biotek, and 3D Systems. Notable market players are adopting various strategies such as, merger, acquisition, new product launch to reap profits in healthcare 3D printing market. For instance, in January 2017, Aspect Biosystems announced research collaboration by DePuy Synthes Products, under agreement that is facilitated by Johnson & Johnson innovation. Additionally, Aspect Biosystems lab on a printer 3D Bioprinting platform would be used for developing bioprinted tissue for knee meniscus for surgical therapy.

Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/1997

Browse Related Reports:

  • Biosensors Market Size 2018 – 2024

Biosensors Market share was valued at over USD 17 billion in 2017 and is expected to witness growth of around 8% CAGR from 2018 to 2024. Increasing prevalence of diabetes has influenced industry growth positively. As per WHO, number of diabetic patients globally in 2014 were around 422 million that have escalated demand for glucose biosensors.
https://www.gminsights.com/industry-analysis/biosensors-market

  • Cell Line Development Market Size 2018 – 2024

Cell Line Development Market share was valued over USD 2.9 Billion in 2016 and is expected to witness more than 13% CAGR from 2017 to 2024. Rising prevalence of cancer and chronic disorders coupled with increasing R&D for technological advancement and favourable government policies for cell line development will boost the cell line development market outlook.
https://www.gminsights.com/industry-analysis/cell-line-development-market-report

About Global Market Insights

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

CONTACT: Contact Us:Arun HegdeCorporate Sales, USAGlobal Market Insights, Inc.Phone: 1-302-846-7766Toll Free: 1-888-689-0688Email: [email protected]: https://www.gminsights.comBlog: https://www.gminsights.com/blogs

Page: 1


Related Keywords:
Related Sites: AEC Newsroom ,   Digital CAD ,   Corporate Media News ,   DMN Newswire ,   CEN - Consumer Electronics Net ,   CEN - HomeOffice ,   CEN - Peripherals ,   CEN - Phones ,   itbusinessnet.com ,   IBN - Business ,   VideoBasedTutorials ,   HTN - Health Technology Net
Related Newsletter: CADList Newsletter ,   CEN - Gadgets Newsletter ,   Tutorial Finder ,   Review Seeker ,   IBN - IT Weekly Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
  • Global Spinal Fusion Devices Market Expected to Reach USD 6.8 Billion By 2024: Zion Market Research

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • ViewRay Announces Pricing of Public Offering of Common Stock
  • Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2012-2018: Deal trends, players, financials and forecasts
  • CASI Pharmaceuticals Announces Second Quarter And First Half 2018 Financial And Business Results
  • Citius Announces Closing of $10.0 Million Underwritten Offering Priced At-the-Market
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines